setmelanotide vs tirzepatide Among participants 4 to 66 years of age with acquired hypothalamic obesity, setmelanotide, a melanocortin-4 receptor agonist, led to significantly greater reductions in body-mass index and hunger than placebo at 52 weeks Novel therapeutics in rare genetic

We know your time is valuable, which is why we offer a no-pressure, no-obligation 15-minute consultation to determine if our programs are the right fit for you.

10.1172/JCI116186 43

they are central to the future of chronic disease management

It's the only medication that activates both GLP-1 and GIP receptors the two hormones that regulate appetite, blood sugar, and how full you feel after eating

Neem dan contact op met je (huis)arts

Imvax Founded: 2015 Technology / disease area: Personalized immunotherapy for solid tumors, with a focus on glioblastoma Lead candidate: IGV-001 Imvax works on personalized immunotherapies for solid tumors, anchored by its proprietary Goldspire platform